Cargando…
Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion
Recent evidence suggests that host immune cells contribute to the development of malignant pleural effusion (MPE), a common manifestation of metastatic cancer. We have identified such cells, predominantly mononuclear myeloid cells, recruited by tumor-orchestrated inflammatory chemokines. Moreover, t...
Autores principales: | Marazioti, Antonia, Stathopoulos, Georgios T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108461/ https://www.ncbi.nlm.nih.gov/pubmed/25083335 http://dx.doi.org/10.4161/onci.29195 |
Ejemplares similares
-
NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
por: Vacca, Paola, et al.
Publicado: (2013) -
Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023) -
Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
por: Marazioti, A, et al.
Publicado: (2019) -
Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion
por: Marazioti, Antonia, et al.
Publicado: (2013) -
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies
por: Derer, Stefanie, et al.
Publicado: (2013)